Use fundamental data analysis to check out all available financial ratios of Micromedic Technologies to find out if markets are presently mispricing the entity. We found twenty-nine available fundamentals for Micromedic Technologies which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Micromedic Technologies Ltd fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales . Use Micromedic Technologies to protect your portfolios against small markets fluctuations. The stock experiences unexpected downward movement. The market is reacting to new fundamentals. Check odds of Micromedic Technologies to be traded at S55.78 in 30 days.
Micromedic Technologies Company Summary
Micromedic Technologies Ltd. engages in the development and commercialization of in vitro cancer diagnostic products and solutions in Israel. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Micromedic Technologies operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange.
Micromedic Technologies EBITDA vs Return On Equity
Micromedic Technologies Ltd is considered to be number one stock in ebitda category among related companies. It is considered to be number one stock in return on equity category among related companies .
|Return On Equity ( % )|
Micromedic Technologies Market Fundamentals
Micromedic Technologies April 22, 2019 Opportunity Range
|Value At Risk||(7.20)|